Azenta (AZTA) to Release Quarterly Earnings on Wednesday

Key Points

• Azenta (NASDAQ:AZTA) will report Q2 2026 results before the market opens on Wednesday, May 6, 2026; analysts expect $0.10 EPS and revenue of about $149.28 million.
• In the prior quarter Azenta reported $0.09 EPS—missing estimates by $0.02—while revenue was $148.64 million, up 0.8% year-over-year, reflecting modest top-line growth but mixed profitability metrics.
• Shares opened at $24.24 (down 3.6%), the company has a market cap of roughly $1.12 billion, institutional investors own about 99% of the stock, and the consensus analyst rating is Hold with a $41.33 target.

Azenta (NASDAQ:AZTA - Get Free Report) is projected to issue its Q2 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $149.2770 million for the quarter. Parties can check the company's upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:30 AM ET.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.02). Azenta had a negative net margin of 10.34% and a positive return on equity of 1.43%. The firm had revenue of $148.64 million for the quarter, compared to analysts' expectations of $146.89 million. During the same quarter in the previous year, the business earned $0.08 EPS. The company's revenue for the quarter was up .8% on a year-over-year basis.

Azenta Stock Down 3.6%

NASDAQ AZTA opened at $24.24 on Wednesday. The stock's 50-day simple moving average is $23.89 and its two-hundred day simple moving average is $30.38. Azenta has a twelve month low of $19.87 and a twelve month high of $41.73. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of -17.96 and a beta of 1.47.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AZTA. Millennium Management LLC increased its holdings in Azenta by 41.6% during the 3rd quarter. Millennium Management LLC now owns 1,698,562 shares of the company's stock valued at $48,783,000 after purchasing an additional 499,216 shares during the period. Scopia Capital Management LP purchased a new position in Azenta during the 3rd quarter valued at about $14,026,000. Quantinno Capital Management LP increased its holdings in Azenta by 192.0% during the 2nd quarter. Quantinno Capital Management LP now owns 713,939 shares of the company's stock valued at $21,975,000 after purchasing an additional 469,447 shares during the period. Park West Asset Management LLC increased its holdings in Azenta by 57.8% during the 4th quarter. Park West Asset Management LLC now owns 700,003 shares of the company's stock valued at $23,282,000 after purchasing an additional 256,488 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in Azenta by 49.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 722,576 shares of the company's stock valued at $22,241,000 after purchasing an additional 238,444 shares during the period. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Zacks Research upgraded Azenta from a "strong sell" rating to a "hold" rating in a report on Monday, January 26th. Jefferies Financial Group decreased their price objective on Azenta from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, February 4th. TD Cowen reiterated a "hold" rating on shares of Azenta in a report on Wednesday, February 4th. Needham & Company LLC reiterated a "buy" rating and issued a $44.00 price objective on shares of Azenta in a report on Tuesday, March 17th. Finally, Evercore decreased their price objective on Azenta from $50.00 to $45.00 and set an "outperform" rating on the stock in a report on Thursday, February 5th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $41.33.

About Azenta

Azenta, Inc NASDAQ: AZTA is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta's Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.